[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "KEYNOTE-C16"
            },
            {
                "name": "Study Protocol Other Identifier",
                "value": "KNC16"
            }
        ],
        "amendment_date": null,
        "keywords": [
            "metastatic solid tumors",
            "advanced solid tumors",
            "Phase 1",
            "SRF388",
            "IL-27",
            "safety",
            "efficacy",
            "immunotherapy",
            "cancer",
            "immuno-oncology",
            "kidney cancer",
            "renal cell carcinoma",
            "liver cancer",
            "hepatocellular carcinoma",
            "non-small cell lung cancer",
            "pembrolizumab",
            "PD-1"
        ],
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "Surface Oncology",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "\u2265 18 years of age"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Locally advanced or metastatic (Stage IV) solid tumor that has progressed during or after standard therapy, and for whom no available therapies are appropriate (based on investigator judgment)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Patients in Part B with advanced or metastatic ccRCC, HCC, or NSCLC must have at least 1 measurable lesion per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Patients with HCC in Part B must have at least 1 measurable target lesion according to modified RECIST (mRECIST)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Patients with HCC must have unresectable disease, Barcelona Clinic Liver Cancer (BCLC1) Stage B (not eligible for transcatheter arterial chemoembolization [TACE]) or Stage C"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "For patients in Part B with ccRCC, demonstrated progressive disease (PD) during or after the most recent treatment regimen. Prior treatment history must include progression during or after treatment with regimen(s) that have included a vascular endothelial growth growth factor (VEGF)-targeted agent and an immune checkpoint inhibitor. Patients who did not progress on but discontinued the VEGF-targeted agent for toxicity or intolerability are permitted."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "For patients in Part B with HCC, demonstrated PD during or after the most recent treatment regimen. Prior treatment history must include progression during or after treatment with a VEGF-targeted agent. Patients who did not progress on but discontinued the VEGF-targeted agent for toxicity or intolerability are permitted."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "For Part B patients in the tumor biopsy subsets only, must have tumor tissue that is accessible for pretreatment and on-treatment tumor biopsy in the opinion of the Investigator and be willing to undergo pretreatment and on-treatment biopsies per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Serum creatinine clearance \u2265 30 mL/min per Cockcroft-Gault formula or serum creatinine \u2264 2.0 x the upper limit of normal (ULN)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Total bilirubin \u2264 1.5 x ULN (\u2264 3 x ULN if elevated because of Gilbert's syndrome and \u2264 2 x ULN for patients with HCC or patients with known liver metastases)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Aspartate aminotransferase (AST/SGOT) and alanine aminotransferase/serum glutamic pyruvic transaminase (ALT/SGPT) < 2.5 x ULN (< 5 x ULN if liver metastasis or for patients with HCC)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "For patients with HCC, Child-Pugh class A or B7 with a serum albumin \u2265 2.8 g/dL (\u2265 28 g/L)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Adequate hematologic function, defined as absolute neutrophil count (ANC) \u2265 1.0 x 109/L, hemoglobin \u2265 9.0 g/dL, and platelet count \u2265 100 x 109/L. For patients with HCC, platelet count \u2265 75 x 109/L without transfusion"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Eastern Cooperative Oncology Group (ECOG) performance status 0-1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "Patients with NSCLC must have histologically confirmed locally advanced and/or metastatic Stave IV NSCLC"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "Patients with NSCLC must have demonstrated progressive disease during or after the most recent treatment regimen Part C Abbreviated Inclusion Criteria:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "\u2265 18 years of age"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "Advanced RCC of any histology or advanced HCC previously treated with at least one systemic anticancer therapy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "Patients with HCC must have unresectable disease, Barcelona Clinic Liver Cancer (BCLC) Stage B (not eligible for transcatheter arterial chemoembolization) or Stage C"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "At least 1 measurable lesion per RECIST 1.1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 20,
                    "description": "Patients with HCC must have at least 1 measurable target lesion according to modified RECIST (mRECIST)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 21,
                    "description": "ECOG performance status of 0-1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 22,
                    "description": "ANC \u22651500/\u00b5L (1.5 x 109/L)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 23,
                    "description": "Platelets \u2265100 000/\u00b5L (\u2265 100 x 109/L)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 24,
                    "description": "Hemoglobin for participants with RCC: \u22659.0 g/dL; for participants with HCC: \u22658.5 g/dL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 25,
                    "description": "Creatinine OR measured or calculated creatinine clearance (GFR can also be used in place of creatinine or CrCl) \u22641.5 \u00d7 ULN OR \u226530 mL/min for participant with creatinine levels >1.5 \u00d7 institutional ULN"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 26,
                    "description": "Total bilirubin \u22641.5 \u00d7 ULN OR direct bilirubin \u2264ULN for participants with total bilirubin levels >1.5 \u00d7 ULN"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 27,
                    "description": "AST (SGOT) and ALT (SGPT) \u22642.5 \u00d7 ULN (\u22645 \u00d7 ULN for participants with liver metastases)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 28,
                    "description": "International normalized ratio (INR) OR prothrombin time (PT) Activated partial thromboplastin time (aPTT) \u22641.5 \u00d7 ULN unless participant is receiving anticoagulant therapy as long as PT or aPTT is within therapeutic range of intended use of anticoagulants"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 29,
                    "description": "For patients with HCC, Child-Pugh Class A or B7 with a serum albumin \u2265 2.8 g/dL (\u2265 28 g/L)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 30,
                    "description": "Willingness of male and female patients who are not surgically sterile or postmenopausal to use medically acceptable methods of birth control for the duration of the study drug period (or beginning 14 days before the initiation of pembrolizumab for oral contraception), including 75 days after the last dose of SRF388 or 120 days after the last dose of pembrolizumab; male patients must refrain from donating sperm during this period. Sexually active men, and women using oral contraceptive pills, should also use barrier contraception with spermicide. Azoospermic male patients and WCBP who are continuously not heterosexually active are exempt from contraceptive requirements. However, female patients must still undergo pregnancy testing as described in this section. Part C Abbreviated Inclusion Criteria Specific to Patients with RCC or HCC from Part A or Part B:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 31,
                    "description": "Progressed on SRF388 by RECIST 1.1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 32,
                    "description": "Did not experience prior Grade \u2265 3 toxicity related to SRF388"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 33,
                    "description": "Willingness to undergo pretreatment core or excisional biopsy if deemed safe and tumor is accessible, in the opinion of the Investigator"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 34,
                    "description": "Has received no systemic anticancer therapies between SRF388 doses"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 35,
                    "description": "Previously received an anti-IL-27 antibody or anti-IL-27 targeted therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 36,
                    "description": "For patients in Part B with renal cell carcinoma (RCC), non-clear cell RCC histology"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 37,
                    "description": "For patients with HCC, known fibrolamellar or mixed hepatocellular cholangiocarcinoma"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 38,
                    "description": "For patients with HCC, fibrolamellar or mixed hepatocellular cholangiocarcinoma"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 39,
                    "description": "History of Grade 4 allergic or anaphylactic reaction to any monoclonal antibody therapy or any excipient in the study drugs"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 40,
                    "description": "Major surgery within 4 weeks prior to Screening"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 41,
                    "description": "Unstable or severe uncontrolled medical condition (eg, unstable cardiac function, unstable pulmonary condition including pneumonitis and/or interstitial lung disease, uncontrolled diabetes) or any important medical illness or abnormal laboratory finding that would, in the Investigator's judgment, increase the risk to the patient associated with his or her participation in the study Part C Abbreviated Exclusion Criteria:"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 42,
                    "description": "Is currently participating in or has participated in a study of an investigational agent or has used an investigational device within 4 weeks prior to the first dose of study drug"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 43,
                    "description": "Previously received an anti-IL 27 antibody or anti-IL 27 targeted therapy (exception to patients who received SRF388 in Part A or Part B)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 44,
                    "description": "No prior systemic therapy for unresectable or metastatic disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 45,
                    "description": "Received > 5 prior systemic regimens for unresectible or metastatic disease (prior PD-(L)1 inhibitors are allowed if the patient did not discontinue therapy due to \u2265 Grade 3 drug-related toxicity)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 46,
                    "description": "For patients with HCC, fibrolamellar histology or mixed hepatocellular cholangiocarcinoma"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 47,
                    "description": "For patients with HCC, moderate or severe ascites"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 48,
                    "description": "For patients with HCC, inability to undergo disease evaluation with triphasic computed tomography or magnetic resonance imaging because of contrast allergy or other contraindication"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 49,
                    "description": "For patients with HCC, imaging findings consistent with \u2265 50% liver occupation by HCC tumors"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 50,
                    "description": "History of Grade 4 allergic or anaphylactic reaction to any monoclonal antibody therapy or any excipient in the study drugs"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 51,
                    "description": "Surgeries that required general anesthesia must be completed at least 2 weeks before first study drug administration"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 52,
                    "description": "Prior autologous stem cell transplant \u2264 3 months before the first dose"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 53,
                    "description": "Prior allogeneic hematopoietic cell transplant within 6 months of the first dose or with a history of or current clinical Graft-Versus-Host Disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 54,
                    "description": "Has had an allogenic tissue/solid organ transplant"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 55,
                    "description": "Other unstable or severe uncontrolled medical condition (eg, unstable cardiac function, unstable pulmonary condition, uncontrolled diabetes) or any important medical illness or abnormal laboratory finding that would, in the Investigator's judgment, increase the risk to the patient associated with his or her participation in the study"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "This is a Phase 1/1b, open-label, first-in-human (FIH), dose-escalation and expansion study\r\n      of SRF388, a monoclonal antibody targeting IL-27, as a monotherapy and in combination in\r\n      patients with solid tumors that will be conducted in 3 parts:\r\n\r\n        -  Part A: SRF388 monotherapy dose-escalation portion of the study will evaluate the\r\n           safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of SRF388 as\r\n           monotherapy in patients with advanced solid tumors.\r\n\r\n        -  Part B: SRF388 monotherapy expansion cohorts will evaluate the safety, efficacy,\r\n           tolerability, PK, and pharmacodynamics of SRF388 monotherapy in patients with advanced\r\n           or metastatic ccRCC, advanced or metastatic HCC, and advanced or metastatic NSCLC in\r\n           indication specific cohorts.\r\n\r\n        -  Part C will evaluate the safety, preliminary efficacy, tolerability, and PK of SRF388 in\r\n           combination with pembrolizumab in patients with advanced RCC or HCC.",
        "official_title": "A Phase 1/1b Study of SRF388 in Patients With Advanced Solid Tumors",
        "_phase_sort_order": 4,
        "collaborators": [
            {
                "name": "Merck and Company Inc",
                "functional_role": "LABORATORY"
            }
        ],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Assessed during first 28 days of treatment",
                "name": "[Part A] Dose Limiting Toxicity (DLT)",
                "description": "Evaluation of DLT of SRF388 as a monotherapy.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part A, Part B, Part C] Disease control rate (DCR)",
                "description": "DCR is defined as the percentage of patients with CR, partial PR, or stable disease lasting a minimum of 12 weeks.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part A, Part B, Part C] Duration of response (DoR)",
                "description": "DoR is defined as the time from the first documented response (CR or PR) to documented disease progression as determined by applicable disease criteria, or documented death due to any cause, whichever occurs first.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part A, Part B, Part C] Pharmacokinetics (PK) of SRF388",
                "description": "Serum concentrations of SRF388 will be collected and analyzed to evaluate the PK of SRF388.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part A, Part B, Part C] Progression-free survival (PFS)",
                "description": "PFS is defined as the time from the first treatment on study with study drug to documented disease progression as determined by applicable disease criteria or death.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part A, Part B] Pharmacodynamics of SRF388 (pSTAT levels)",
                "description": "Pharmacodynamics of SRF388 will be evaluated in immune cell subsets via whole blood.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part A, Part B] Safety Analysis: Summary of adverse events (AEs) and based on treatment-emergent AEs (TEAEs)",
                "description": "Safety and tolerability of SRF388 will be assessed by summarizing adverse events (AEs) and will be based on treatment-emergent AEs (TEAEs).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part A, Part C] Objective response rate (ORR)",
                "description": "ORR will be estimated by the percentage of patients achieving a best overall response of CR or PR per RECIST v1.1 and iRECIST.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part B] Confirmed objective response rate (ORR)",
                "description": "ORR will be estimated by the percentage of patients achieving a best overall response of CR or PR per RECIST v1.1 and iRECIST.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part C] Anti-drug Antibodies (ADAs) to SRF388",
                "description": "Serum will be collected and assessed for the development of ADAs to SRF388.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Assessed during first 21 days of treatment",
                "name": "[Part C] DLT",
                "description": "Evaluation of DLT of SRF388 in combination with pembrolizumab.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part C] Serum concentration of EBI3",
                "description": "Serum will be collected to assess EBI3 correlation with outcomes.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "[Part C] Summary of adverse events (AEs) based on treatment emergent AEs (TEAEs)",
                "description": "Safety and tolerability of SRF388 + pembrolizumab will be assessed by summarizing AEs and will be based on TEAEs. A TEAE is an AE that emerges or worsens in the period from the first dose of study treatment to 30 days after the last dose of study drug assessed by per CTCAE version 5.0 or higher.",
                "type_code": "PRIMARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 3,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04374877",
        "biomarkers": [],
        "classification_code": null,
        "current_trial_status_date": "2020-04-22",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "BCLC Stage B Hepatocellular Carcinoma",
                    "Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C115136",
                "name": "BCLC Stage B Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C115132"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "BCLC Stage C Hepatocellular Carcinoma",
                    "Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C115137",
                "name": "BCLC Stage C Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C115132"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Solid Tumor",
                    "Metastatic Tumor",
                    "Metastatic Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Malignant Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Solid Neoplasm",
                    "Advanced Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C127155",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Solid Tumor",
                    "Locally Advanced Malignant Solid Neoplasm",
                    "Locally Advanced Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133093",
                "name": "Locally Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Liver Cell Carcinoma AJCC v8",
                    "Stage III Hepatocellular Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134520",
                "name": "Stage III Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7118",
                    "C134515"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "IIIA",
                    "Stage IIIA Hepatocellular Carcinoma AJCC v8",
                    "Stage IIIA Liver Cell Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134521",
                "name": "Stage IIIA Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134520"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "IIIB",
                    "Stage IIIB Hepatocellular Carcinoma AJCC v8",
                    "Stage IIIB Liver Cell Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134522",
                "name": "Stage IIIB Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134520"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Liver Cell Carcinoma AJCC v8",
                    "Stage IV Hepatocellular Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134523",
                "name": "Stage IV Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134515",
                    "C7121"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Hepatocellular Carcinoma AJCC v8",
                    "IVA",
                    "Stage IVA Liver Cell Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134524",
                "name": "Stage IVA Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7122",
                    "C134523"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVB Liver Cell Carcinoma AJCC v8",
                    "IVB",
                    "Stage IVB Hepatocellular Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134525",
                "name": "Stage IVB Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7123",
                    "C134523"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Renal Cell Cancer AJCC v8",
                    "Stage IV Renal Cell Carcinoma AJCC v8",
                    "Stage IV"
                ],
                "nci_thesaurus_concept_id": "C140326",
                "name": "Stage IV Renal Cell Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140322"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162768",
                "name": "Metastatic Clear Cell Renal Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4033",
                    "C150595"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Hepatocellular Carcinoma",
                    "Non-Resectable Hepatocellular Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C27345",
                "name": "Unresectable Hepatocellular Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C165171",
                    "C3099"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Tumour",
                    "Solid tumor, NOS",
                    "Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Genitourinary Disorder",
                    "Urogenital Disease"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of the Urinary System",
                    "Tumor of the Urinary System",
                    "Tumor of Urinary System",
                    "Tumor of the Urinary Tract",
                    "Neoplasm of Urinary System",
                    "Urinary System Tumor",
                    "Neoplasm of the Urinary Tract",
                    "Tumor of Urinary Tract",
                    "Urinary Tract Tumor",
                    "Urinary Tract Neoplasm",
                    "Neoplasm of Urinary Tract"
                ],
                "nci_thesaurus_concept_id": "C3431",
                "name": "Urinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3430",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Renal and Ureteral Tumor",
                    "Kidney and Ureter Tumor",
                    "Renal and Ureteral Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7514",
                "name": "Kidney and Ureter Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3431"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Liver and Biliary System Neoplasm",
                    "Malignant Liver and Biliary Neoplasm",
                    "Malignant Hepato-Biliary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8609",
                "name": "Malignant Hepatobiliary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4890",
                    "C8614"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of Kidney",
                    "Tumor of the Kidney",
                    "Neoplasm of Kidney",
                    "Renal Tumor",
                    "Kidney Neoplasm",
                    "Neoplasm of the Kidney",
                    "Renal Neoplasm",
                    "Renal Tumors"
                ],
                "nci_thesaurus_concept_id": "C3150",
                "name": "Kidney Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3149",
                    "C7514"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Non-Resectable Malignant Neoplasm of Liver",
                    "Non-Resectable Malignant Liver Neoplasm",
                    "Non-Resectable Hepatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C35648",
                "name": "Unresectable Malignant Liver Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8609",
                    "C7103",
                    "C162845"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urothelial tract/bladder cancer, NOS",
                    "Malignant Urinary Tract Neoplasm",
                    "Urothelial/bladder cancer, NOS",
                    "Urinary Tract Cancer"
                ],
                "nci_thesaurus_concept_id": "C9297",
                "name": "Malignant Urinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3431"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Liver Cell Carcinoma by AJCC v8 Stage",
                    "Tumor Stage (Pathologic)"
                ],
                "nci_thesaurus_concept_id": "C134515",
                "name": "Hepatocellular Carcinoma by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C3099"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of GI System",
                    "Tumor of Digestive System",
                    "Digestive Tumor",
                    "GI Neoplasm",
                    "Neoplasm of the Gastrointestinal System",
                    "Digestive System Tumor",
                    "Gastrointestinal Tumor",
                    "Neoplasm of the Digestive System",
                    "Tumor of the Gastrointestinal System",
                    "Neoplasm of Digestive System",
                    "Tumor of the Digestive System",
                    "Gastrointestinal System Tumor",
                    "Gastrointestinal Neoplasm",
                    "GI Tumor",
                    "Tumor of Gastrointestinal System",
                    "Gastrointestinal System Neoplasm",
                    "Neoplasm of the GI System",
                    "GI System Tumor",
                    "GI System Neoplasm",
                    "Neoplasm of Gastrointestinal System",
                    "Tumor of the GI System",
                    "Digestive Neoplasm",
                    "Neoplasm of GI System"
                ],
                "nci_thesaurus_concept_id": "C3052",
                "name": "Digestive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C2990"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Genitourinary Neoplasm",
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Hepatic and Biliary Neoplasms",
                    "Hepato-Biliary Neoplasm",
                    "Liver and Biliary Neoplasm",
                    "Hepato-Biliary Tumor",
                    "Liver and Biliary System Neoplasm",
                    "Hepatic, Biliary, and Gallbladder Neoplasms",
                    "Hepatic and Biliary Tumors",
                    "Hepatobiliary Tumors",
                    "Hepatobiliary Tumor"
                ],
                "nci_thesaurus_concept_id": "C8614",
                "name": "Hepatobiliary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3052",
                    "C3959"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C155903",
                "name": "Unresectable Digestive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C96963",
                    "C148124",
                    "C162845"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Renal Neoplasm",
                    "Malignant Kidney Tumor",
                    "Malignant Tumor of the Kidney",
                    "Malignant Neoplasm of the Kidney",
                    "Malignant Neoplasm of Kidney",
                    "Malignant Tumor of Kidney",
                    "Malignant Renal Tumor"
                ],
                "nci_thesaurus_concept_id": "C7548",
                "name": "Malignant Kidney Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3150",
                    "C9297"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Renal Cell Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C150595",
                "name": "Metastatic Renal Cell Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27806",
                    "C9385",
                    "C4124"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Cancer",
                    "Locally advanced",
                    "regional cancer",
                    "Locally Metastatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8524",
                "name": "Locally Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Liver Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7121",
                "name": "Stage IV Liver Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7927"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Cancer of the Liver",
                    "Liver Carcinoma",
                    "Liver/hepatobiliary cancer",
                    "Cancer of Liver",
                    "Liver and hepatobiliary cancer, NOS",
                    "Liver and Intrahepatic Biliary Tract Cancer",
                    "Cancer of the Liver and Intrahepatic Biliary Tract",
                    "Liver and Intrahepatic Bile Duct Carcinoma",
                    "Liver and Intrahepatic Bile Duct Cancer",
                    "Cancer of Liver and Intrahepatic Biliary Tract",
                    "Liver and Intrahepatic Biliary Tract Carcinoma",
                    "Biliary Tract Cancer",
                    "Primary Liver Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7927",
                "name": "Liver Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C34803",
                    "C7106",
                    "C96963"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C27359",
                "name": "Unresectable Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Gastrointestinal System Disorder",
                    "Unspecified Gastrointestinal Problem",
                    "Disorder of Digestive System",
                    "stomach or intestinal disorder",
                    "GI Disorder",
                    "Gastrointestinal Disorder",
                    "Digestive System Disease",
                    "Gastrointestinal System Disease",
                    "Digestive Disease"
                ],
                "nci_thesaurus_concept_id": "C2990",
                "name": "Digestive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Kidney Adenocarcinoma",
                    "Renal Cell Adenocarcinoma",
                    "Renal cell carcinoma, NOS",
                    "CARCINOMA, RENAL CELL, MALIGNANT",
                    "Renal Cell Carcinoma, Stage Unspecified",
                    "Adenocarcinoma of Kidney",
                    "RCC",
                    "Renal cell carcinoma, unclassified",
                    "Renal Cell Carcinoma",
                    "Adenocarcinoma of the Kidney"
                ],
                "nci_thesaurus_concept_id": "C9385",
                "name": "Renal Cell Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C9384"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Renal Carcinoma",
                    "Kidney Cancer",
                    "Kidney cancer, NOS",
                    "Kidney Carcinoma",
                    "Renal Cancer"
                ],
                "nci_thesaurus_concept_id": "C9384",
                "name": "Kidney (including Renal Cell) Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7548",
                    "C181197"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Malignant Genitourinary System Neoplasm",
                    "Metastatic Genitourinary System Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C157774",
                "name": "Metastatic Genitourinary Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C156484"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165171",
                "name": "Unresectable Liver and Intrahepatic Bile Duct Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C129654",
                    "C35648",
                    "C7927"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C27806",
                "name": "Metastatic Kidney Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9384",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Liver Disorder",
                    "Liver Disease",
                    "Hepatic Disorder"
                ],
                "nci_thesaurus_concept_id": "C3196",
                "name": "Liver and Intrahepatic Bile Duct Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3959"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Mesonephroid Clear Cell Carcinoma",
                    "Clear Cell Carcinoma",
                    "Mesonephroid Clear Cell Adenocarcinoma",
                    "Clear cell adenocarcinoma, NOS",
                    "ADENOCARCINOMA, CLEAR CELL, MALIGNANT",
                    "Clear cell adenocarcinoma, mesonephroid"
                ],
                "nci_thesaurus_concept_id": "C3766",
                "name": "Clear Cell Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Gastrointestinal System Adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C129654",
                "name": "Unresectable Digestive System Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C155903",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Primary Malignant Neoplasm of Liver"
                ],
                "nci_thesaurus_concept_id": "C34803",
                "name": "Primary Malignant Liver Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8609",
                    "C7103"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148124",
                "name": "Unresectable Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C27359"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C4124",
                "name": "Metastatic Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "CARCINOMA, HEPATOCELLULAR, MALIGNANT",
                    "Hepatocellular Carcinoma",
                    "Carcinoma of the Liver Cells",
                    "Liver Cell Carcinoma",
                    "LIHC",
                    "Carcinoma of Liver Cells",
                    "HCC",
                    "Hepatoma",
                    "Primary Carcinoma of the Liver Cells",
                    "Primary Carcinoma of Liver Cells",
                    "Liver Cell Cancer (Hepatocellular Carcinoma)"
                ],
                "nci_thesaurus_concept_id": "C3099",
                "name": "Hepatocellular Cancer",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C7927"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Urinary System",
                    "Urinary Tract Disorder",
                    "Urologic Disorder",
                    "Urinary Tract Disease",
                    "Urological Disorders"
                ],
                "nci_thesaurus_concept_id": "C3430",
                "name": "Urinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Gastrointestinal System Neoplasm",
                    "Gastrointestinal cancer, NOS",
                    "Gastrointestinal System Cancer",
                    "Malignant Digestive System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C4890",
                "name": "Malignant Gastrointestinal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3052"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7106",
                "name": "Liver and Intrahepatic Bile Duct Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7103"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Genitourinary Cancer",
                    "Metastatic Genitourinary Carcinoma",
                    "Metastatic Urogenital Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C146893",
                "name": "Metastatic Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C164141",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Barcelona Clinic Liver Cancer Staging for Hepatocellular Carcinoma",
                    "Hepatocellular Carcinoma BCLC Staging",
                    "Hepatocellular Carcinoma by Barcelona Clinic Liver Cancer Stage",
                    "BCLC Staging for Hepatocellular Carcinoma",
                    "Hepatocellular Carcinoma Barcelona Clinic Liver Cancer Staging"
                ],
                "nci_thesaurus_concept_id": "C115132",
                "name": "Hepatocellular Carcinoma by BCLC Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C3099"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Conventional (Clear Cell) Renal Cell Adenocarcinoma",
                    "Renal Clear Cell Carcinoma",
                    "Kidney Clear Cell Carcinoma",
                    "Renal Clear Cell Adenocarcinoma",
                    "Clear Cell Adenocarcinoma, Kidney",
                    "Hypernephroma",
                    "Conventional Renal Cell Carcinoma",
                    "Grawitz Tumor",
                    "Clear Cell Carcinoma of the Kidney",
                    "Clear Cell Adenocarcinoma of Kidney",
                    "Clear Cell Carcinoma of Kidney",
                    "Kidney Clear Cell Adenocarcinoma",
                    "Conventional (Clear Cell) Renal Cell Carcinoma",
                    "CCRCC",
                    "RCC, clear cell adenocarcinoma",
                    "Clear Cell Renal Cell Carcinoma",
                    "Renal cell carcinoma, clear cell adenocarcinoma",
                    "Clear Cell Adenocarcinoma of the Kidney",
                    "Hypernephroid tumor"
                ],
                "nci_thesaurus_concept_id": "C4033",
                "name": "Clear Cell Renal Cell Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9385",
                    "C3766"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma of the Gastrointestinal System",
                    "Gastrointestinal System Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C96963",
                "name": "Digestive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Hepatic and Intrahepatic Bile Duct Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7103",
                "name": "Liver and Intrahepatic Bile Duct Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3196",
                    "C8614"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVB Liver Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7123",
                "name": "Stage IVB Liver Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7121"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Liver Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7118",
                "name": "Stage III Liver Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7927"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Stage (Pathological)",
                    "Renal Cell Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140322",
                "name": "Renal Cell Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9385"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Liver Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7122",
                "name": "Stage IVA Liver Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7121"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Kidney Disease",
                    "Renal Disorder",
                    "Renal Disorder, NOS",
                    "Renal Disease"
                ],
                "nci_thesaurus_concept_id": "C3149",
                "name": "Kidney Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3430"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181197",
                "name": "Urinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C9297"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162845",
                "name": "Unresectable Malignant Digestive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27359",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Liver and Biliary System Disorder",
                    "Liver and Biliary Disease",
                    "Liver and Biliary Disorder",
                    "Liver Disease"
                ],
                "nci_thesaurus_concept_id": "C3959",
                "name": "Hepatobiliary Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2990"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "SRF388-101",
        "active_sites_count": 17,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C174410",
                        "name": "Anti-IL-27p28 Monoclonal Antibody SRF388",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biomodulators",
                            "Biological Response Modifier",
                            "BRM",
                            "Immunopotentiators",
                            "Immunomodulatory Agent",
                            "Immune Regulators",
                            "Immune Modulators",
                            "Immunotherapeutic Agent",
                            "Immunotherapy Agent",
                            "Immune Mediators",
                            "Immunomodulators",
                            "Immunomodulating Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biopharmaceuticals",
                            "Biologics",
                            "Biological Products",
                            "Immunologics",
                            "Biologicals",
                            "Immunologic, Immunochemical"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmaceutical Agent",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceuticals",
                            "Pharmacologic Agent",
                            "Drug Substance"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Part A Monotherapy Dose Escalation",
                "description": "The Part A monotherapy dose escalation portion of the study will evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of SRF388 as monotherapy in up to 42 patients with advanced solid tumors.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part B Indication-specific SRF388 Monotherapy Expansion",
                "description": "Part B monotherapy expansion will evaluate the safety, tolerability, PK, pharmacodynamics, and efficacy of SRF388 monotherapy at the recommended phase 2 dose (RP2D) in up to 40 patients with ccRCC, up to 40 patients with HCC, and up to 40 patients with NSCLC.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part C SRF388 in Combination with Pembrolizumab",
                "description": "Part C will evaluate the safety, preliminary efficacy, tolerability, and PK of SRF388 in combination with pembrolizumab in patients with advanced RCC or HCC.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2020-07076",
        "why_study_stopped": null,
        "brief_summary": "This is a Phase 1/1b, open-label, first-in-human, dose-escalation and expansion study of\r\n      SRF388, a monoclonal antibody that targets IL-27, as a monotherapy and in combination in\r\n      patients with solid tumors.",
        "brief_title": "Study of SRF388 in Patients With Advanced Solid Tumors",
        "status_history": [
            {
                "status_date": "2020-04-22T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 180,
        "_current_trial_status_sort_order": 0,
        "start_date": "2020-04-22",
        "record_verification_date": "2022-01-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2023-07-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]